Common drug shows promise against rare type of heart disease
A research team co-led by scientists at the University of Arizona College of Medicine - Tucson found that an osteoporosis drug might counter a rare genetic mutation underlying a type of heart disease. The results were published today in the Journal of Clinical Investigation and could have implications for treating other rare diseases. Dilated cardiomyopathy is a group of disorders defined by weak cardiac muscles.
A research team co-led by scientists at the University of Arizona College of Medicine - Tucson found that an osteoporosis drug might counter a rare genetic mutation underlying a type of heart disease. The results were published today in the Journal of Clinical Investigation and could have implications for treating other rare diseases.
Dilated cardiomyopathy is a group of disorders defined by weak cardiac muscles.
